PILENKO THIERRY

SEC source: 0001104659-21-061285 · tm2115180-3_4seq1.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 42,816 shares

Expires not disclosed

F4 · derivative.exercise_price: Upon the vesting of the restricted share units, the reporting person is required to pay the aggregate nominal value (par value), $0.40 per share, of the Class A ordinary shares actually issued, in accordance with applicable corporate law. On June 3, 2019, the reporting person was granted 22,806 restricted share units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F1 · kind: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · kind: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F5 · kind: On the Effective Date, all outstanding restricted share units were cancelled and extinguished in accordance with the Plan approved by the Bankruptcy Court.

F4 · derivative.exercise_date: Upon the vesting of the restricted share units, the reporting person is required to pay the aggregate nominal value (par value), $0.40 per share, of the Class A ordinary shares actually issued, in accordance with applicable corporate law. On June 3, 2019, the reporting person was granted 22,806 restricted share units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: Upon the vesting of the restricted share units, the reporting person is required to pay the aggregate nominal value (par value), $0.40 per share, of the Class A ordinary shares actually issued, in accordance with applicable corporate law. On June 3, 2019, the reporting person was granted 22,806 restricted share units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001104659-21-061285 · tm2115180-3_4seq1.xml · derivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19

Underlying: Common Shares · 19 shares

Expires 2028-04-29

F1 · kind: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · kind: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F3 · kind: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

F1 · price: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · price: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F3 · price: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

F3 · derivative.exercise_date: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

SEC source: 0001104659-21-061880 · tm2115331d3_4aseq1.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 42,186 shares

Expires not disclosed

F4 · derivative.exercise_price: On the Effective Date, all outstanding restricted share units were cancelled and extinguished in accordance with the Plan approved by the Bankruptcy Court.

F1 · kind: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · kind: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F4 · kind: On the Effective Date, all outstanding restricted share units were cancelled and extinguished in accordance with the Plan approved by the Bankruptcy Court.

F4 · derivative.exercise_date: On the Effective Date, all outstanding restricted share units were cancelled and extinguished in accordance with the Plan approved by the Bankruptcy Court.

F4 · derivative.expiration_date: On the Effective Date, all outstanding restricted share units were cancelled and extinguished in accordance with the Plan approved by the Bankruptcy Court.

SEC source: 0001104659-21-061880 · tm2115331d3_4aseq1.xml · derivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19

Underlying: Common Shares · 19 shares

Expires 2028-04-29

F1 · kind: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · kind: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F3 · kind: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

F1 · price: On August 19, 2020, Valaris plc ("Legacy Valaris") and certain of its wholly owned direct and indirect subsidiaries (collectively, the "Debtors") commenced voluntary cases (the "Chapter 11 Cases") under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"). On March 3, 2021, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code (as amended, modified or supplemented from time to time, the "Plan").

F2 · price: In connection with the Chapter 11 Cases and the Plan, on and prior to the Effective Date (as defined below), the Company effectuated certain restructuring transactions, pursuant to which Valaris Limited, a Bermuda exempted company (the "Issuer") was formed and - through a series of transactions - Legacy Valaris transferred to a subsidiary of the Issuer substantially all of the subsidiaries, and other assets, of Legacy Valaris. On April 30, 2021 (the "Effective Date"), the Plan became effective in accordance with its terms and the Issuer emerged from chapter 11.

F3 · price: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

F3 · derivative.exercise_date: On the Effective Date, the Reporting Person received Warrants (the "Warrants") to purchase common shares, par value $0.01 per share, of the Issuer (the "Common Shares"), with respect to Legacy Valaris ordinary shares (the "Existing Equity Interest") held by the Reporting Person on the Effective Date at an effective exchange ratio of 0.0274975 of a Warrant for each share of Exiting Equity Interest. The Warrants are exercisable for one Common Share from the date of issuance until 5:00 p.m., New York time, on the Expiration Date. The receipt of the Warrants was involuntary, without additional consideration and in accordance with the Plan approved by the Bankruptcy Court.

SEC source: 0000314808-19-000112 · wf-form4_155977583150792.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,806

Underlying: Class A Ordinary Shares · 22,806 shares

Expires not disclosed

F1 · derivative.exercise_price: Upon the vesting of our restricted share units, the reporting person is required to pay the aggregate nominal value (par value), $0.40 per share, of our Class A ordinary shares actually issued, in accordance with U.K. corporate law.

F2 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 22,806 restricted share units, vesting on the first anniversary of the grant date.

F2 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 22,806 restricted share units, vesting on the first anniversary of the grant date.

SEC source: 0001104659-19-020928 · a4.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,381

Underlying: Class A Ordinary Shares · 19,381 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents Ensco restricted share units received by the reporting person at the effective time of the Transaction in exchange for his restricted share units to acquire 28,191 Class A ordinary shares of Rowan. Each restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of Ensco, or a combination thereof, at the discretion of the compensation committee of the Board of Directors of Ensco.

F2 · price: Represents Ensco restricted share units received by the reporting person at the effective time of the Transaction in exchange for his restricted share units to acquire 28,191 Class A ordinary shares of Rowan. Each restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of Ensco, or a combination thereof, at the discretion of the compensation committee of the Board of Directors of Ensco.

F2 · derivative.exercise_date: Represents Ensco restricted share units received by the reporting person at the effective time of the Transaction in exchange for his restricted share units to acquire 28,191 Class A ordinary shares of Rowan. Each restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of Ensco, or a combination thereof, at the discretion of the compensation committee of the Board of Directors of Ensco.

F2 · derivative.expiration_date: Represents Ensco restricted share units received by the reporting person at the effective time of the Transaction in exchange for his restricted share units to acquire 28,191 Class A ordinary shares of Rowan. Each restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of Ensco, or a combination thereof, at the discretion of the compensation committee of the Board of Directors of Ensco.

SEC source: 0001104659-19-020928 · a4.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 687

F1 · shares: Pursuant to the Transaction Agreement, dated as of October 7, 2019, between Ensco plc ("Ensco") and Rowan Companies plc ("Rowan"), Ensco acquired the entire issued and to be issued share capital of Rowan on April 11, 2019 (the "Transaction"). At the effective time of the Transaction, each Class A ordinary share of Rowan issued and outstanding immediately prior to such time was converted into the right to receive 2.750 shares of Ensco's Class A ordinary shares. Immediately following the effective time of the Transaction, Ensco effected a consolidation whereby every four existing Class A ordinary shares of Ensco were consolidated into one Class A ordinary share of Ensco, and Ensco changed its name to "Ensco Rowan plc." On the trading day immediately prior to the effective time of the Transaction, the closing price of Ensco was $3.97 per share, and the closing price of Rowan was $10.93 per share.

SEC source: 0001144204-19-019390 · tv518773_form4.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 28,191 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of the Company, or a combination thereof, at the discretion of the compensation committee of the Rowan Board of Directors.

F3 · shares: Pursuant to the Transaction Agreement, each outstanding restricted share unit award granted to a non-employee member of Rowan's Board of Directors ("DU Award"), whether vested or unvested, was converted on the same terms and conditions (including applicable vesting conditions) applicable to such DU Award under the applicable Company equity plan and award agreement in effect immediately prior to the closing of the transaction ("Closing") into a restricted stock unit of Ensco covering a number of Ensco Class A ordinary shares, rounded down to the nearest whole share, determined by multiplying the number of Rowan ordinary shares subject to such Rowan DU Award immediately prior to Closing by the exchange ratio of 2.750 Class A ordinary shares of Ensco for each Rowan Class A ordinary share. There was no purchase price.

F3 · derivative.exercise_date: Pursuant to the Transaction Agreement, each outstanding restricted share unit award granted to a non-employee member of Rowan's Board of Directors ("DU Award"), whether vested or unvested, was converted on the same terms and conditions (including applicable vesting conditions) applicable to such DU Award under the applicable Company equity plan and award agreement in effect immediately prior to the closing of the transaction ("Closing") into a restricted stock unit of Ensco covering a number of Ensco Class A ordinary shares, rounded down to the nearest whole share, determined by multiplying the number of Rowan ordinary shares subject to such Rowan DU Award immediately prior to Closing by the exchange ratio of 2.750 Class A ordinary shares of Ensco for each Rowan Class A ordinary share. There was no purchase price.

F3 · derivative.expiration_date: Pursuant to the Transaction Agreement, each outstanding restricted share unit award granted to a non-employee member of Rowan's Board of Directors ("DU Award"), whether vested or unvested, was converted on the same terms and conditions (including applicable vesting conditions) applicable to such DU Award under the applicable Company equity plan and award agreement in effect immediately prior to the closing of the transaction ("Closing") into a restricted stock unit of Ensco covering a number of Ensco Class A ordinary shares, rounded down to the nearest whole share, determined by multiplying the number of Rowan ordinary shares subject to such Rowan DU Award immediately prior to Closing by the exchange ratio of 2.750 Class A ordinary shares of Ensco for each Rowan Class A ordinary share. There was no purchase price.

SEC source: 0001144204-19-019390 · tv518773_form4.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: On April 11, 2019, pursuant to the Transaction Agreement by and between Ensco plc ("Ensco") and Rowan Companies plc (the "Company" or "Rowan"), dated as of October 7, 2018, (as amended, the "Transaction Agreement"), each of the issued and outstanding Class A ordinary shares of the Company were exchanged pursuant to a court-sanctioned scheme of arrangement for 2.750 Class A ordinary shares of Ensco, each with a nominal value of $0.10.

F1 · price: On April 11, 2019, pursuant to the Transaction Agreement by and between Ensco plc ("Ensco") and Rowan Companies plc (the "Company" or "Rowan"), dated as of October 7, 2018, (as amended, the "Transaction Agreement"), each of the issued and outstanding Class A ordinary shares of the Company were exchanged pursuant to a court-sanctioned scheme of arrangement for 2.750 Class A ordinary shares of Ensco, each with a nominal value of $0.10.

SEC source: 0001681459-19-000004 · wf-form4_155061097596275.xml · nonDerivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 814,001

F2 · shares: On December 6, 2016, the Reporting Person was granted restricted stock units subject to certain performance criteria. On February 18, 2019, the Compensation Committee certified the performance level pursuant to the terms of the award, and as a result, 58,000 restricted stock units were awarded, each of which represents a contingent right to receive one Ordinary Share that will vest on December 6, 2020.

SEC source: 0001681459-19-000004 · wf-form4_155061097596275.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 756,001

F1 · shares: On July 1, 2016, the Reporting Person was granted restricted stock units subject to certain performance criteria. On February 18, 2019, the Compensation Committee certified the performance level pursuant to the terms of the award, and as a result, 132,000 restricted stock units were awarded, each of which represents a contingent right to receive one Ordinary Share that will vest on July 1, 2020.

SEC source: 0000085408-18-000079 · wf-form4_152763113666708.xml · derivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,191

Underlying: Class A Ordinary Shares · 13,080 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted share unit represents a contingent right to receive cash, one Class A Ordinary Share of Rowan Companies plc, or a combination thereof, at the discretion of the compensation committee of the board of directors of Rowan Companies plc.

F2 · derivative.exercise_date: Each deferred restricted share unit vests on the earlier of the first anniversary of the date of the grant or the date of the next annual general meeting of shareholders of Rowan Companies plc. Each deferred restricted share unit settles upon the termination of the reporting person's service on the board of directors of Rowan Companies plc. Each restricted share unit settles in cash, Class A Ordinary Shares of Rowan Companies plc, or a combination thereof, at the discretion of the compensation committee of the board of directors of Rowan Companies plc.

F2 · derivative.expiration_date: Each deferred restricted share unit vests on the earlier of the first anniversary of the date of the grant or the date of the next annual general meeting of shareholders of Rowan Companies plc. Each deferred restricted share unit settles upon the termination of the reporting person's service on the board of directors of Rowan Companies plc. Each restricted share unit settles in cash, Class A Ordinary Shares of Rowan Companies plc, or a combination thereof, at the discretion of the compensation committee of the board of directors of Rowan Companies plc.

SEC source: 0001681459-18-000019 · wf-form4_151925206875224.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 624,001

F1 · shares: Grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, that will vest on September 7, 2019.

SEC source: 0001681459-17-000247 · wf-form4_150248274859731.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,001

F1 · shares: Grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, that will vest on February 28, 2020.

SEC source: 0001681459-17-000221 · wf-form4_149747204751598.xml · derivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,300

Underlying: Ordinary Shares · 77,300 shares

Expires 2021-06-14

F1 · derivative.exercise_price: The option is exercisable at an exercise price of 42.87EUR per ordinary share.

F2 · shares: On January 17, 2017, the reporting person was granted an option to purchase 100,000 ordinary shares at a price of 42.87EUR per ordinary share. The vesting of the option was subject to certain performance criteria that were partially met, resulting in the vesting of the option as to 77,300 ordinary shares.

SEC source: 0001209191-17-036293 · doc4.xml · derivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,111

Underlying: Class A Ordinary Shares · 15,111 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted share unit represents a contingent right to receive one Class A Ordinary Share of Rowan Companies plc, or at the discretion of the Compensation Committee, such settlement may be made in cash, shares or a combination.

F2 · derivative.exercise_date: The restricted share units vest on the earlier of May 25, 2018 or the date of the next annual meeting of shareholders but are not settled until departure from the Board.

F2 · derivative.expiration_date: The restricted share units vest on the earlier of May 25, 2018 or the date of the next annual meeting of shareholders but are not settled until departure from the Board.

F3 · balance_after: Includes 15,111 deferred restricted shares units which settle upon departure from the Board, in cash, shares or a combination, at the discretion of the Compensation Committee.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · derivative · entry 6

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Ordinary Shares · 230,000 shares

Expires 2024-07-01

F2 · security: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F3 · derivative.exercise_price: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F8 · derivative.exercise_price: The option will vest on July 1, 2020 and will be exercisable at an exercise price of 24.17EUR per ordinary share.

F3 · shares: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F2 · price: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F8 · derivative.exercise_date: The option will vest on July 1, 2020 and will be exercisable at an exercise price of 24.17EUR per ordinary share.

F2 · derivative.underlying: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · derivative · entry 5

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,000

Underlying: Ordinary Shares · 220,000 shares

Expires 2023-09-07

F2 · security: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F3 · derivative.exercise_price: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F7 · derivative.exercise_price: The option will vest on September 7, 2019 and will be exercisable at an exercise price of 23.92EUR per ordinary share.

F3 · shares: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F2 · price: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F7 · derivative.exercise_date: The option will vest on September 7, 2019 and will be exercisable at an exercise price of 23.92EUR per ordinary share.

F2 · derivative.underlying: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · derivative · entry 4

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Ordinary Shares · 100,000 shares

Expires 2021-06-14

F2 · security: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F3 · derivative.exercise_price: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F6 · derivative.exercise_price: The option will vest on June 14, 2017 and will be exercisable at an exercise price of 42.87EUR per ordinary share.

F3 · shares: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F2 · price: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F6 · derivative.exercise_date: The option will vest on June 14, 2017 and will be exercisable at an exercise price of 42.87EUR per ordinary share.

F2 · derivative.underlying: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · derivative · entry 3

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,570

Underlying: Ordinary Shares · 97,570 shares

Expires 2019-06-15

F2 · security: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F3 · derivative.exercise_price: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F5 · derivative.exercise_price: The option is fully vested and immediately exercisable at an exercise price of 37.27EUR per ordinary share.

F3 · shares: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F2 · price: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F5 · derivative.exercise_date: The option is fully vested and immediately exercisable at an exercise price of 37.27EUR per ordinary share.

F2 · derivative.underlying: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · derivative · entry 2

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,160

Underlying: Ordinary Shares · 132,160 shares

Expires 2018-06-17

F2 · security: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F3 · derivative.exercise_price: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F4 · derivative.exercise_price: The option is fully vested and immediately exercisable at an exercise price of 36.35EUR per ordinary share.

F3 · shares: Pursuant to the BCA, (i) the number of ordinary shares of the Issuer subject to each Issuer Option is equal to the product of (x) the number of ordinary shares of Technip subject to the Technip Option immediately prior to the Effective Time and (y) the Exchange Ratio (rounded down to the nearest whole number) and (ii) each Issuer Option has an exercise price per ordinary share of the Issuer equal to (a) the exercise price per ordinary share of Technip immediately prior to the Effective Time divided by (b) the Exchange Ratio (rounded up to the nearest whole cent), subject to the terms of the BCA.

F2 · price: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

F4 · derivative.exercise_date: The option is fully vested and immediately exercisable at an exercise price of 36.35EUR per ordinary share.

F2 · derivative.underlying: Pursuant to the BCA, each option to purchase or subscribe for Technip ordinary shares (a "Technip Option"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to purchase ordinary shares of the Issuer (an "Issuer Option"), subject to the terms of the BCA.

SEC source: 0001681459-17-000108 · wf-form4_148478562780204.xml · nonDerivative · entry 1

PILENKO THIERRY · CIK 0001282307 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 477,000

F1 · price: Pursuant to the Business Combination Agreement, dated as of June 14, 2016 (the "BCA") by and among the Issuer, FMC Technologies, Inc. ("FMCTI") and Technip S.A. ("Technip"), each ordinary share of Technip beneficially owned by the Reporting Person at the effective time of the transactions contemplated by the BCA (the "Effective Time") was exchanged for 2.00 ordinary shares of the Issuer (the "Exchange Ratio").